
FDA Q&A Document on Addressing Misinformation About Devices and Drugs: Terminology and Background
The new article further describes in detail the scope of matters covered by the guidance, as well as the relevant legal background.
The new article further describes in detail the scope of matters covered by the guidance, as well as the relevant legal background.
The new article clarifies the regulatory approach to be applied with respect to tailored responsive communication.
The new article explains the matters related to general medical product communication in the context of addressing misinformation about the products.
The article outlines the key points to be included in the application for authorization to conduct clinical trials in Denmark.
The article highlights the key points related to the regulatory requirements for dental curing lights intended to be marketed and used in the US.